Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Aprea Therapeutics Inc
Profile last edited on: 3/11/2024      CAGE: 9DVZ8      UEI: P4B7EG3NM1T6

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2022
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3805 Old Easton Road
Doylestown, PA 18902
   (267) 221-6713
   info@aprea.com
   www.aprea.com
Location: Multiple
Congr. District: 01
County: Bucks

Public Profile

Aprea Therapeutics is a clinical stage, platform biotechnology company focused on the development of novel, synthetic lethality-based therapies with direct on-target mechanisms of action and clear clinical pathways.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$862,205
Phase II Dollars
$0
Total Awarded
$862,205

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
0 1 NIH $862,205
Project Title: Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous ovarian cancer

Key People / Management

  Oren Gilad -- President and CEO

  Mike Carleton -- Translational Medicine Advisor

  John P Hamill -- Senior Vice President And Chief Financial Officer

  Nadeem Mirza -- Senior Medical Advisor

  Ze’ev Weiss -- Chief Business Advisor

  Nancy Young

Company News

There are no news available.